Join
Live feed
·
PRReleasevia Quantisnow
Barinthus Biotherapeutics plc logo

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

ByQuantisnow·Wall Street's wire, on your screen.
BRNS· Barinthus Biotherapeutics plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BRNS (Barinthus Biotherapeutics plc) and more on Quantisnow.